Category: Uncategorized

IVI GROUP SHOWCASES INTEGRATED TELEHEALTH AT ATS 2026: WHY VIETNAM’S DIGITAL HEALTH MARKET IS SHIFTING FROM STANDALONE APPS TO CONNECTED CARE INFRASTRUCTURE

21/10/2026 Published by HealthBiz

Key Development IVI Group has presented an integrated digital healthcare ecosystem at the Asia Telemedicine Summit 2026 (ATS 2026), combining... Read more

Tags: #Vietnam

ESKAR EARNS VIETNAM NATIONAL BRAND RECOGNITION AGAIN: WHY STERILE MANUFACTURING QUALITY IS BECOMING A COMPETITIVE ASSET FOR DOMESTIC PHARMA

21/10/2026 Published by HealthBiz

Key Development DK Pharma's Eskar eye drops have been recognized under the Vietnam National Brand Programme for a second consecutive... Read more

Category: Uncategorized

Tags: #Vietnam

IMEXPHARM INVESTS IN PHARMACIST EDUCATION: WHY VIETNAM’S OTC MARKET IS SHIFTING FROM PRODUCT DISTRIBUTION TO PROFESSIONAL VALUE

21/10/2026 Published by HealthBiz

Key Development Imexpharm has supported two scientific sessions at Vietnam's fifth Expanded Community Pharmacists Conference, bringing clinical knowledge and pharmaceutical... Read more

Category: Uncategorized

Tags: #Vietnam

PENNSYLVANIA MEASLES CASES REACH 1,286: WHY VACCINATION COVERAGE, NOT VACCINE AVAILABILITY ALONE, IS THE NEXT PUBLIC HEALTH CHALLENGE

20/10/2026 Published by HealthBiz

Key Development Pennsylvania has confirmed 1,286 measles cases across 42 counties in 2026, reinforcing concerns about the return of a... Read more

Category: Uncategorized

Tags: #Global Trends

MERCK’S $1.3 BILLION SILENCE THERAPEUTICS DEAL: WHY RNAi PLATFORMS ARE BECOMING STRATEGIC ASSETS IN PHARMACEUTICAL M&A

20/10/2026 Published by HealthBiz

Key Development Germany's Merck KGaA has agreed to acquire UK-based Silence Therapeutics for approximately $1.3 billion, expanding its position in... Read more

Category: Uncategorized

Tags: #M&A

UNILEVER EXITS WELLY: WHY CONSUMER HEALTHCARE M&A IS SHIFTING FROM BRAND OWNERSHIP TO PORTFOLIO PRODUCTIVITY

20/10/2026 Published by HealthBiz

Key Development Unilever has agreed to sell Welly Health PBC, the U.S. first-aid brand known for its colorful adhesive bandages... Read more

Category: Uncategorized

Tags: #M&A

DISC MEDICINE REBOUNDS FROM FDA REJECTION WITH PHASE 3 SUCCESS: WHY CLINICAL BENEFIT, NOT BIOMARKER IMPROVEMENT ALONE, IS THE REAL CURRENCY OF DRUG APPROVAL

20/10/2026 Published by HealthBiz

Key Development Disc Medicine has reported positive Phase 3 results for bitopertin, its investigational oral treatment for erythropoietic protoporphyria (EPP),... Read more

Category: Uncategorized

Tags: #Global Trends

GILEAD’S ORAL IBD DRUG ACHIEVES 31% REMISSION: THE NEXT IMMUNOLOGY BATTLE MAY BE WON BY COMBINING BIOLOGIC PRECISION WITH PILL CONVENIENCE

20/10/2026 Published by HealthBiz

Key Development Gilead Sciences has reported positive Phase 2 results for emvistegrast (GS-1427), its once-daily oral α4β7 integrin inhibitor for... Read more

Category: Uncategorized

Tags: #Global Trends